Plasmacytoma usually affects the bone marrow, but the incidence of extramedullary plasmacytoma is 5% of all plasma-cell neoplasms. The vast majority of extramedullary plasmacytomas present as a tumor secondary to systemic myelomatosis of the bone marrow; extramedullary plasmacytoma involving the pancreas is very rare, and only 19 cases have been reported in the English-language literature (1). A few such reports have described the radiologic findings (1), but to the best of our knowledge, none have described the US, CT, and MR imaging findings in patients in whom multifocal involvement of extramedullary plasmacytoma and an initial diagnosis of multiple myeloma were simultaneous. We present the US, CT, and MR findings of pancreatic plasmacytoma in a patient with multiple myeloma.
nal failure. On admission, the results of physical examination were unremarkable: liver function test results were within normal limits, with a total bilirubin level of 0.8 mg/dl; the hemoglobin (Hb) level was 8.7 g/dl, that of creatinine was 5.99 mg/dl, and the creatinine clearance ratio was 6.9 ml/min. During further evaluation, however, the IgG level was found to be 3550 mg/dl, and at immunoelectrophoresis, the presence of an abnormal band of IgG and two lambda-type bands was noted.
Abdominal US revealed that the pancreatic head contained a mixed echoic mass, 5 cm in diameter and with an internal hypoechoic component (Fig. 1A) . Contrastenhanced helical CT scanning of the abdomen, performed 70 seconds after the injection of contrast medium, demonstrated a poorly defined mass in the pancreatic head and body. Contour bulging and moderate contrast enhancement were noted (Fig. 1B) . T1-weighted MR imaging indicated that the pancreatic head and body contained masses of low to intermediate signal intensity (SI) (Fig. 1C) , and at gadolinium-enhanced MR imaging, these showed strong contrast enhancement ( diagnosed, and pathologically confirmed (Fig. 1F) .
Discussion
Multiple myeloma is a disease in which a malignant proliferation of plasma cells typically involves medullary bones. Myelomatosis, a solitary bone myeloma, or an extramedullary plasmacytoma are all possible, but involvement of the retroperitoneum is rare (2) . Most extramedullary plasmacytomas are solitary, but occasionally they disseminate, usually in conjunction with systemic myelomatosis (3). Extramedullary plasmacytoma involving the pancreas is very rare.
The CT imaging findings of plasmacytoma of the pancras have been described as an isodense mass (1, 4, 5) , of low SI at T1WI and high SI at T2WI (6), or diffuse pancreatic enlargement suggestive of pancreatitis (7). This same report noted that at dynamid MR, a pancreatic plasmacytoma showed poor enhancement compared to normal pancreatic parenchyma. In our case, however, the opposite was true.
The differential diagnosis of pancreatic plasmacytoma must determine whether autoimmune pancreatitis and pancreatic lymphoma, primary or secondary, are present. At CT, an extramedullary plasmacytoma which occupies the retroperitoneal space may appear similar to a lymphoma (8) , and without a clinical history of multiple myeloma, the diagnosis of extramedullary plasmacytoma at preoperative imaging may be very difficult. Differential diagnosis has included primary or secondary pancreatic tumor, lymphoma, and pancreatic inflammation.
In our case, the diagnosis of pancreatic plasmacytoma and simultaneous multiple myeloma was confirmed by percutaneous US-guided biopsy, the importance of which, according to several published reports (1 5), lies in its minimal invasiveness. So far published in which the US, CT, and MR findings of pancreatic plasmacytoma are described ; in our study, complete initial imaging studies -other than angiography -were performed.
Although the imaging findings of extramedullary plasmacytoma of the pancreas are nonspecific, differential diagnosis is required when a pancreatic mass is present in a patient with a plasma cell-neoplasm. Because of the high radiosensitivity of this tumor, unnecessary surgery can be avoided.
